Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report

BACKGROUND: Capecitabine is used in combination with lapatinib as palliative treatment for human epidermal growth factor receptor 2 - positive metastatic breast cancer. The most frequently reported adverse events attributed to capecitabine include diarrhea, hyperbilirubinemia, and hand-foot syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Ha Rim, Lee, Sang-Kyung, Youn, Hyun Jo, Yun, Seok-Kweon, Lee, Il-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173406/
https://www.ncbi.nlm.nih.gov/pubmed/34141791
http://dx.doi.org/10.12998/wjcc.v9.i17.4279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173406/
https://www.ncbi.nlm.nih.gov/pubmed/34141791
http://dx.doi.org/10.12998/wjcc.v9.i17.4279

Ejemplares similares